Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alphamab Oncology Announces First Patient Dosed in the Pivotal Clinical Study of KN046 for the Treatment of PD-(L)1 Refractory Advanced NSCLC 2021-10-29 09:36
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity 2021-10-29 09:27
ImmunoForge Inc. receives U.S. FDA ODD for PF1801 2021-10-29 05:50
Jubilee Biotech has developed JUBIwatch, "Health and Life are now wearable" 2021-10-28 21:00
HanAll Biopharma Reports Third Quarter 2021 Results 2021-10-28 21:00
BioVaxys Further Expands Intellectual Property Portfolio in Global Markets 2021-10-28 20:00
Interim report for Q3 2021 : Bactiguard Holding AB (publ) 2021-10-28 15:23
Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease (cGvHD) in Adults 2021-10-28 05:48
Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing 2021-10-27 23:40
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:08
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:06
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:03
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore 2021-10-27 20:52
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients 2021-10-27 20:47
Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production 2021-10-26 20:00
I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China 2021-10-26 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 2021-10-26 07:30
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage 2021-10-25 20:30
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management 2021-10-25 19:00
1 215 216 217 218 219 413